Search for: "Mylan LLC" Results 241 - 260 of 266
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Apr 2008, 1:00 am
: (creativecommons.org), Neil Netanel’s copyright paradox: (Patry Copyright Blog), Isn’t it ironic: TechCrunch blames the music industry for the dangerous ideas of Lessig and the free culture movement: (IPcentral.com) CFP: First interdisciplinary research workshop on free culture: (creativecommons.org), Of limitations, exceptions and verse (WIPO copyright committee): (KEI) Pharma & Biotech Pharma & Biotech - General StemCellPatents.com… [read post]
7 Jul 2022, 7:15 am by David Hemming (Bristows)
Continuing, he also noted that in Warner-Lambert Co LLC v Generics (UK) Ltd (t/a Mylan) [2018] UKSC 56, the Supreme Court “upheld the distinction drawn between amendments to delete claims that have been held to be invalid and amendments designed to make good a claim not thus far advanced in the amended form”, in other words confirming that what the Court of Appeal had said in IPCom and Nikken was correct. [read post]
17 Oct 2023, 3:40 pm by Rik Lambers (Brinkhof)
– – – – – – – – – – – [1] At least, as to foreign judgments, this was considered in PI proceedings in DC Amsterdam 6 January 2023, DIVX/Netlfix, and confirmed in this decision. [2] In particular in view of CoA The Hague 15 August 2023, BMS/Sandoz (Apixaban). [3] Warner-Lambert Company LLC (Respondent) v Generics (UK) Ltd v, Mylan and another (Appellants) [2018] UKSC 56. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Coalition for Affordable Drugs (ADROCA) LLC v.Acorda Therapeutics, Inc., Nos. [read post]
6 Mar 2014, 12:41 pm
Because Bexis is updating chapter two (information-based claims) of his book, he has some ideas for some shorter lists of interesting cases. [read post]
28 Mar 2014, 5:33 pm
.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
28 Mar 2008, 6:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Forbes interview with M Meurer (co author of ‘Patent Failure’): (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (IAM), (Technological Innovation and Intellectual Property), (Patent Prospector),Rambus – Rambus stock soars following jury’s dismissal of antitrust and fraud charges from Hynix, Micron, and Nanya that… [read post]
17 Oct 2013, 5:00 am by Bexis
For some reason, we recently found ourselves comparing our favorite defenses to our favorite rock bands. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
23 Oct 2008, 9:03 am
It got hardly any attention in the blawgosphere at the time - aside from us, 360, and the hardcore Supreme Court junkies over at SCOTUSBlog (and even they buried it in the middle of a routine post) - but earlier this month the Supreme Court indicated interest in the certiorari petition from the Farm Raised Salmon case. [read post]
31 Mar 2010, 1:58 pm
Pressure Products Medical Supplies invented a valve remover for an introducer, netting 5,125,904 & 5,312,355. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]